Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis.
Rallis
E
E
Papatheodorou
G
G
Bimpakis
E
E
Butanska
D
D
Menounos
P
P
Papadakis
P
P
D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004819:Epidermodysplasia Verruciformis / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000188:drug therapy*; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male
D003879:Dermatologic Agents; D015474:Isotretinoin